Pharmacoeconomics of obesity in China: a scoping review
Background: With the growing rate of obesity and associated chronic conditions in China, there is a need to assess the health and economic burdens of obesity and examine the effectiveness of pharmaceutical, medical, and comprehensive weight-loss interventions. Areas covered: This article reviewed pu...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor and Francis Ltd.
2021
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/65238/ |
| _version_ | 1848800202318675968 |
|---|---|
| author | Chen, Zhuo Jiang, Shan Wang, Youfa Khan, M. Mahmud Zhang, Donglan Rajbhandari-Thapa, Janani Li, Li |
| author_facet | Chen, Zhuo Jiang, Shan Wang, Youfa Khan, M. Mahmud Zhang, Donglan Rajbhandari-Thapa, Janani Li, Li |
| author_sort | Chen, Zhuo |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | Background: With the growing rate of obesity and associated chronic conditions in China, there is a need to assess the health and economic burdens of obesity and examine the effectiveness of pharmaceutical, medical, and comprehensive weight-loss interventions. Areas covered: This article reviewed publications retrieved from PubMed and Google Scholar during 2010–2020 on pharmacoeconomic studies related to overweight and obesity in China. We identified five cost-of-illness studies and four cost-effectiveness analyses of weight-loss interventions, including bariatric surgeries and a comprehensive intervention program. Expert opinion: There is a lack of pharmacoeconomic analyses of obesity in China. Existing studies have often taken the health system perspective without accounting for productivity loss. Cohort studies and studies based on electronic health records or claims data are needed to provide the epidemiologic parameters required for homegrown economic evaluations of the health and economic burdens of obesity in China, as well as the cost-effectiveness of interventions to reduce obesity and its sequela. |
| first_indexed | 2025-11-14T20:47:49Z |
| format | Article |
| id | nottingham-65238 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T20:47:49Z |
| publishDate | 2021 |
| publisher | Taylor and Francis Ltd. |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-652382021-05-07T08:55:35Z https://eprints.nottingham.ac.uk/65238/ Pharmacoeconomics of obesity in China: a scoping review Chen, Zhuo Jiang, Shan Wang, Youfa Khan, M. Mahmud Zhang, Donglan Rajbhandari-Thapa, Janani Li, Li Background: With the growing rate of obesity and associated chronic conditions in China, there is a need to assess the health and economic burdens of obesity and examine the effectiveness of pharmaceutical, medical, and comprehensive weight-loss interventions. Areas covered: This article reviewed publications retrieved from PubMed and Google Scholar during 2010–2020 on pharmacoeconomic studies related to overweight and obesity in China. We identified five cost-of-illness studies and four cost-effectiveness analyses of weight-loss interventions, including bariatric surgeries and a comprehensive intervention program. Expert opinion: There is a lack of pharmacoeconomic analyses of obesity in China. Existing studies have often taken the health system perspective without accounting for productivity loss. Cohort studies and studies based on electronic health records or claims data are needed to provide the epidemiologic parameters required for homegrown economic evaluations of the health and economic burdens of obesity in China, as well as the cost-effectiveness of interventions to reduce obesity and its sequela. Taylor and Francis Ltd. 2021-02-09 Article PeerReviewed application/pdf en cc_by https://eprints.nottingham.ac.uk/65238/1/043015393801MergePDF.pdf Chen, Zhuo, Jiang, Shan, Wang, Youfa, Khan, M. Mahmud, Zhang, Donglan, Rajbhandari-Thapa, Janani and Li, Li (2021) Pharmacoeconomics of obesity in China: a scoping review. Expert Review of Pharmacoeconomics & Outcomes Research, 21 (2). pp. 173-181. ISSN 1473-7167 Bariatric surgery； China； cost-effectiveness； cost-of-illness； economic evaluation； obesity； overweight http://dx.doi.org/10.1080/14737167.2021.1882306 doi:10.1080/14737167.2021.1882306 doi:10.1080/14737167.2021.1882306 |
| spellingShingle | Bariatric surgery； China； cost-effectiveness； cost-of-illness； economic evaluation； obesity； overweight Chen, Zhuo Jiang, Shan Wang, Youfa Khan, M. Mahmud Zhang, Donglan Rajbhandari-Thapa, Janani Li, Li Pharmacoeconomics of obesity in China: a scoping review |
| title | Pharmacoeconomics of obesity in China: a scoping review |
| title_full | Pharmacoeconomics of obesity in China: a scoping review |
| title_fullStr | Pharmacoeconomics of obesity in China: a scoping review |
| title_full_unstemmed | Pharmacoeconomics of obesity in China: a scoping review |
| title_short | Pharmacoeconomics of obesity in China: a scoping review |
| title_sort | pharmacoeconomics of obesity in china: a scoping review |
| topic | Bariatric surgery； China； cost-effectiveness； cost-of-illness； economic evaluation； obesity； overweight |
| url | https://eprints.nottingham.ac.uk/65238/ https://eprints.nottingham.ac.uk/65238/ https://eprints.nottingham.ac.uk/65238/ |